Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1387 of 5804
-
New therapy aims to stop depression before it starts in At-Risk teens
Prevention Recruiting nowYouth exposed to early life adversity (ELA) are known to be at greater risk for depression and suicidality and account for almost half of the youth suffering from psychiatric diseases today. Youth exposed to ELA consistently report symptoms of anhedonia as well as dysregulated po…
Phase: NA • Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Foster care study tests new parenting program to stop behavior issues early
Prevention Recruiting nowThe primary objective of this study is to test the effects of an evidence-based prevention intervention (CPP) adapted for foster and kinship caregivers of young children (FC; foster care) on caregiver competence and child behavior problems for children in foster care compared wit…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Psychedelic showdown: psilocybin vs ketamine for heavy drinkers
Disease control OngoingThis pilot study will collect preliminary data that measures the effects of psilocybin-assisted psychotherapy vs ketamine-assisted psychotherapy on patients struggling with alcohol use.
Phase: PHASE2 • Sponsor: Peggy C Nopoulos • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug shows promise for severe pneumonia patients in ICU
Disease control CompletedThe goal of this clinical trial is to compare the safety and efficacy of AON-D21 versus placebo, both on top of standard of care, in patients with severe community acquired pneumonia admitted to ICU (or similar unit). The main questions to answer are: * The safety and tolerabili…
Phase: PHASE2 • Sponsor: Aptarion Biotech AG • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can a phone app help teens with HIV stick with treatment?
Disease control OngoingThis is a cluster randomized controlled trial determining the effectiveness of in-person or mHealth-based adolescent-friendly transition interventions compared to standard care on retention in care and viral suppression among adolescents living with HIV who have low transition re…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Race against time: can early angioplasty save diabetic feet?
Symptom relief Recruiting nowThe planned study is a Randomized Controlled Monocentric Trial, which will provide evidence on whether early angiography in percutaneous transluminal angioplasty (PTA) readiness ("immediate" treatment, within 48h) has advantages over the "standard of care", i.e., an elective proc…
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Sleep your way slimmer: new study for breast cancer survivors
Symptom relief Recruiting nowThe investigators propose a randomized controlled clinical trial in 250 women with a history of early stage breast cancer who are overweight or obese with insomnia to test whether a brief, cognitive-behavioral intervention for insomnia (CBT-I) prior to behavioral weight loss (CBT…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New hope for leukemia patients who didn't respond to standard therapy
Disease control Recruiting nowChidamide in combination with venetoclax and azacitidine (VAC) were expected to improve remission rate of patients following to VA regimen treatment failure.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New transgender-focused program aims to curb HIV and substance harm in thailand
Prevention Recruiting nowThis study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
Phase: NA • Sponsor: Institute of HIV Research and Innovation Foundation, Thailand • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Could taking blood thinners only when needed be just as safe as daily pills?
Disease control Recruiting nowThe clinical benefit of pill-in-the-POCKET anticoagulation after atrial fibrillation catheter ablation remains uncertain. We aimed to evaluate the clinical benefit and safety of pill-in-the-POCKET anticoagulation after atrial fibrillation catheter ablation by randomizing into two…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New lung cancer cocktail aims to outperform standard care
Disease control Recruiting nowTo compare the efficacy and safety between teniposide, cisplatin and serplulimab regimen and etoposide, cisplatin and serplulimab regimen in the treatment of extensive stage small lung cancer
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Texts that heal minds: personalized messages boost brain power in lung cancer survivors
Symptom relief CompletedObjective: To evaluate the effectiveness of a personalized motivational messaging intervention designed to improve cognitive function in lung cancer survivors. Hypothesis: Lung cancer survivors who receive personalized motivational messaging will demonstrate significantly greate…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could a bad mood or infection trigger a major stroke? scientists investigate
Knowledge-focused CompletedAcute ischemic stroke has a high incidence, ischemic stroke caused by large vessel occlusion is serious and has a poor prognosis, and its triggers in the short term before onset are not clear. The aim of this study was to evaluate the short-term risk of acute ischemic stroke caus…
Sponsor: Anzhi Li • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Smartwatch-Guided exercise may tame pregnancy risks
Disease control CompletedThe aim of this study is to assess the impact of structured physical activity with smartwatch remote monitoring on glycemic control, blood pressure control, obstetric complications and neonatal outcomes in women with GDM, chronic hypertension and obesity. A prospective, longitudi…
Phase: NA • Sponsor: Unidade Local de Saúde de Coimbra, EPE • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Video game therapy: VR could help kids beat anxiety before it starts
Prevention Recruiting nowIntroduction and Significance: Preventive interventions have been shown to reduce the risk of developing anxiety and depression, making them a critical focus area in mental health promotion for children and adolescents. Enhancing emotion regulation (ER) skills in young people is …
Phase: NA • Sponsor: Universitat Internacional de Catalunya • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Video games and relaxation techniques show promise for boosting seniors' mental health
Symptom relief CompletedThis interventional clinical trial was conducted to evaluate the effects of Antroyun (exergaming) and autogenic relaxation techniques on psychological well-being and life engagement among older adults living in nursing homes. Participants were randomly assigned to one of three gr…
Phase: NA • Sponsor: Cumhuriyet University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New Immune-Cell cocktail takes on tough gut cancers
Disease control OngoingParticipants will receive study treatment with agenT-797, botensilimab, balstilimab, ramucirumab, and paclitaxel. When participants start each agent will depend on how their disease is affecting them.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowAn open label, two-cohort, dose-escalation clinical study to evaluate the safety, anti-tumor activity and pharmacokinetics/pharmacodynamic (PK/PD) of NW-301V and NW-301D in subjects with advanced solid tumor.
Phase: PHASE1 • Sponsor: TingBo Liang • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can virtual reality help kids with autism? new study tests it
Symptom relief CompletedTo explore the effects of immersive virtual reality technology combined with psychological and behavioral intervention on children with autism. Methods: A retrospective study was conducted on the clinical data of 120 children with autism admitted to our hospital from January 2024…
Phase: NA • Sponsor: Tongren Hongxin Kangxin Traditional Chinese Medicine Hospital, Guizhou Province • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Combining GLP-1 drugs with Weight-Loss surgery: better results or just more pills?
Disease control Recruiting nowGlucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the pancreas, control hunger, induce satiety and plays a role in the metabolic health of a person. GLP-1 receptor agonists (GLP1-…
Phase: PHASE4 • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC